| Literature DB >> 33230184 |
Tsuyoshi Murata1,2, Hyo Kyozuka3,4, Akiko Yamaguchi3,4, Toma Fukuda3,4, Shun Yasuda3,4, Akiko Sato3, Yuka Ogata3, Kosei Shinoki3, Mitsuaki Hosoya3,5, Seiji Yasumura3,6, Koichi Hashimoto3,5, Hidekazu Nishigori3,7, Keiya Fujimori3,4.
Abstract
Inappropriate gestational weight gain (GWG), either above or below the recommended values, has been associated with an increased risk of adverse obstetric outcomes. To evaluate the risks of GWG for foetal acidosis according to pre-pregnancy body mass index (BMI) and mode of delivery, we analysed women with singleton pregnancies between 2011 and 2014 in the Japan Environment and Children's Study. Participants (n = 71,799) were categorised according to pre-pregnancy BMI. GWG was categorised into insufficient, appropriate, or excessive. Foetal acidosis was defined as umbilical artery pH (UmA-pH) < 7.20 or < 7.10. Multiple logistic regressions were performed for each BMI category to identify the risks of GWG for foetal acidosis, accounting for the mode of delivery. Excessive GWG was significantly associated with increased foetal acidosis in overweight women and in women whose pre-pregnancy BMI was 23.0-25.0 kg/m2 especially in those with vaginal deliveries. Conversely, excessive GWG was not significantly associated with increased foetal acidosis in obese women and in women whose pre-pregnancy BMI was ≥ 25.0 kg/m2.Entities:
Mesh:
Year: 2020 PMID: 33230184 PMCID: PMC7683683 DOI: 10.1038/s41598-020-77429-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of study enrolment.
Maternal background according to pre-pregnancy body mass index based on 2009 IOM guidelines and Japanese criteria[28].
| Group | GA | GB | GC | GD | P value | |
|---|---|---|---|---|---|---|
| BMI category (kg/m2) | < 18.5 | 18.5–< 25.0 | 25.0–< 30.0 | ≥ 30.0 | ||
| No. patients | 10,935 (15.2%) | 52,903 (73.7%) | 6072 (8.5%) | 1889 (2.6%) | ||
| Maternal age (years), % | ||||||
| < 20 | 0.9 | 0.5 | 0.5 | 0.3 | < 0.001 | |
| 20–29 | 41.9 | 34.9 | 32.0 | 31.6 | ||
| > 30 | 57.2 | 64.5 | 67.6 | 68.2 | ||
| Maternal education (years), % | ||||||
| < 10 | 5.1 | 4.0 | 6.0 | 8.9 | < 0.001 | |
| 10–12 | 30.9 | 29.9 | 38.0 | 43.5 | ||
| 13–16 | 62.5 | 64.6 | 54.9 | 47.0 | ||
| > 17 | 1.5 | 1.4 | 1.1 | 0.5 | ||
| Annual household income (JPY), % | ||||||
| < 2,000,000 | 6.0 | 5.2 | 7.6 | 10.3 | < 0.001 | |
| 2,000,000–5,999,999 | 67.3 | 67.1 | 70.4 | 72.6 | ||
| 6,000,000–9,999,999 | 22.1 | 23.3 | 18.6 | 15.0 | ||
| > 10,000,000 | 4.6 | 4.4 | 3.4 | 2.1 | ||
| Smoking during pregnancy, % | 5.0 | 4.2 | 6.5 | 7.8 | < 0.001 | |
| Primiparous, % | 43.4 | 40.1 | 34.4 | 34.0 | < 0.001 | |
| Gestational age, week (mean ± SD) | 38.7 (1.5) | 38.9 (1.5) | 38.8 (1.6) | 38.6 (1.9) | < 0.001 | |
| PTB before 37 weeks, % | 5.0 | 4.0 | 5.5 | 7.3 | < 0.001 | |
| Birth weight, g (mean ± SD) | 2925 (388) | 3038 (401) | 3115 (454) | 3157 (508) | < 0.001 | |
| SGA infants, % | 7.3 | 4.6 | 4.0 | 3.3 | < 0.001 | |
| Gestational weight gain, kg (mean ± SD) | 10.8 (3.5) | 10.5 (3.8) | 8.6 (10.0) | 5.2 (5.7) | < 0.001 | |
| Caesarean delivery, % (n) | 14.8 (1614) | 18.0 (9506) | 27.3 (1657) | 35.8 (677) | < 0.001 | |
| UmA-pH < 7.2, % | 6.2 | 6.2 | 6.9 | 7.5 | 0.037 | |
| UmA-pH < 7.1, % | 1.1 | 1.2 | 1.3 | 1.3 | 0.554 | |
One-way analysis of variance, Kruskal-Wallis test and the Chi-square test were used to compare continuous and categorical variables, respectively. BMI body mass index, G1 group 1, G2 group 2, G3 group 3, G4 group 4, G5 group 5, GA group A, GB group B, GC group C, GD group D, IOM Institute of Medicine, JPY Japanese yen, PTB preterm birth, SGA small-for-gestational age, UmA-pH umbilical artery pH.
Adjusted odds ratiosa and 95% confidence intervals for foetal acidosis based on gestational weight gain described in the 2009 IOM guidelines.
| BMI category (kg/m2) | Gestational weight gain | ||
|---|---|---|---|
| Insufficient | Appropriate | Excessive | |
| Group A; BMI < 18.5 (n = 10,935) | n = 7920 | n = 2759 | n = 256 |
| Model 1 aOR (95% CI) | 0.92 (0.77–1.10) | Ref | 1.13 (0.69–1.83) |
| Model 2 aOR (95% CI) | 0.88 (0.73–1.05) | Ref | 1.14 (0.70–1.85) |
| Model 3 aOR (95% CI) | 0.88 (0.73–1.05) | Ref | 1.15 (0.71–1.87) |
| Group B; BMI 18.5–< 25.0 (n = 52,903) | n = 31,671 | n = 17,489 | n = 3743 |
| Model 1 aOR (95% CI) | 0.97 (0.90–1.05) | Ref | 1.10 (0.96–1.26) |
| Model 2 aOR (95% CI) | 0.96 (0.89–1.04) | Ref | 1.11 (0.96–1.27) |
| Model 3 aOR (95% CI) | 0.96 (0.89–1.04) | Ref | 1.11 (0.97–1.28) |
| Group C; BMI 25.0–< 30.0 (n = 6072) | n = 2125 | n = 2383 | n = 1564 |
| Model 1 aOR (95% CI) | 0.94 (0.73–1.19) | Ref | 1.27 (0.99–1.62) |
| Model 2 aOR (95% CI) | 0.92 (0.72–1.18) | Ref | 1.27 (0.99–1.62) |
| Model 3 aOR (95% CI) | 0.92 (0.72–1.18) | Ref | 1.27 (0.99–1.62) |
| Group D; BMI ≥ 30 (n = 1889) | n = 888 | n = 567 | n = 434 |
| Model 1 aOR (95% CI) | 0.97 (0.65–1.46) | Ref | 0.98 (0.61–1.57) |
| Model 2 aOR (95% CI) | 0.96 (0.64–1.43) | Ref | 0.99 (0.62–1.60) |
| Model 3 aOR (95% CI) | 0.96 (0.64–1.43) | Ref | 0.99 (0.62–1.60) |
| Group A; BMI < 18.5 (n = 10,935) | n = 7920 | n = 2759 | n = 256 |
| Model 1 aOR (95% CI) | 0.93 (0.61–1.42) | Ref | 1.71 (0.66–4.46) |
| Model 2 aOR (95% CI) | 0.81 (0.53–1.25) | Ref | 1.75 (0.67–4.58) |
| Model 3 aOR (95% CI) | 0.81 (0.53–1.25) | Ref | 1.71 (0.66–4.48) |
| Group B; BMI 18.5–< 25.0 (n = 52,903) | n = 31,671 | n = 17,489 | n = 3743 |
| Model 1 aOR (95% CI) | 1.11 (0.93–1.33) | Ref | 1.33 (0.98–1.80) |
| Model 2 aOR (95% CI) | 1.07 (0.89–1.28) | Ref | 1.35 (0.99–1.83) |
| Model 3 aOR (95% CI) | 1.07 (0.89–1.28) | Ref | 1.35 (0.99–1.82) |
| Group C; BMI 25.0–< 30.0 (n = 6072) | n = 2125 | n = 2383 | n = 1564 |
| Model 1 aOR (95% CI) | 1.33 (0.75–2.38) | Ref | 2.07 (1.19–3.60) |
| Model 2 aOR (95% CI) | 1.26 (0.70–2.25) | Ref | 2.08 (1.19–3.61) |
| Model 3 aOR (95% CI) | 1.26 (0.70–2.25) | Ref | 2.08 (1.19–3.61) |
| Group D; BMI ≥ 30 (n = 1889) | n = 888 | n = 567 | n = 434 |
| Model 1 aOR (95% CI) | 1.94 (0.62–6.08) | Ref | 2.64 (0.80–8.71) |
| Model 2 aOR (95% CI) | 1.80 (0.57–5.67) | Ref | 2.71 (0.82–9.00) |
| Model 3 aOR (95% CI) | 1.80 (0.57–5.67) | Ref | 2.71 (0.82–9.00) |
Logistic regression models were used to calculate the adjusted odds ratios and 95% confidence intervals for UmA-pH < 7.20, with women with appropriate gestational weight gain as the reference. BMI body mass index, IOM Institute of Medicine, UmA-pH umbilical artery pH.
aModel 1 adjusted for maternal age, maternal education, annual household income, maternal smoking during pregnancy, and parity. Model 2 adjusted for covariates in Model 1 and preterm birth and small-for-gestational age infants. Model 3 adjusted for covariates in Model 2 and mode of delivery.
Adjusted odds ratiosa and 95% confidence intervals for foetal acidosis based on gestational weight gain described in Japanese criteria[28].
| BMI category (kg/m2) | Gestational weight gain | ||
|---|---|---|---|
| Insufficient | Appropriate | Excessive | |
| Group 1; BMI < 18.5 (n = 10,935) | n = 5550 | n = 3316 | n = 2069 |
| Model 1 aOR (95% CI) | 0.88 (0.73–1.05) | Ref | 0.98 (0.79–1.23) |
| Model 2 aOR (95% CI) | 0.83 (0.69–0.99) | Ref | 1.00 (0.80–1.25) |
| Model 3 aOR (95% CI) | 0.83 (0.69–0.99) | Ref | 1.00 (0.80–1.25) |
| Group 2; BMI 18.5–< 20.0 (n = 17,418) | n = 6310 | n = 6229 | n = 4879 |
| Model 1 aOR (95% CI) | 0.99 (0.85–1.15) | Ref | 1.10 (0.94–1.29) |
| Model 2 aOR (95% CI) | 0.98 (0.84–1.14) | Ref | 1.10 (0.94–1.30) |
| Model 3 aOR (95% CI) | 0.98 (0.84–1.14) | Ref | 1.11 (0.95–1.30) |
| Group 3; BMI 20.0–< 23.0 (n = 27,835) | n = 7248 | n = 9849 | n = 10,738 |
| Model 1 aOR (95% CI) | 0.95 (0.84–1.08) | Ref | 1.01 (0.90–1.13) |
| Model 2 aOR (95% CI) | 0.94 (0.83–1.07) | Ref | 1.01 (0.91–1.13) |
| Model 3 aOR (95% CI) | 0.94 (0.83–1.07) | Ref | 1.02 (0.91–1.14) |
| Group 4; BMI 23.0–< 25.0 (n = 7650) | n = 1054 | n = 2622 | n = 3974 |
| Model 1 aOR (95% CI) | 0.94 (0.69–1.29) | Ref | 1.21 (0.99–1.49) |
| Model 2 aOR (95% CI) | 0.91 (0.66–1.24) | Ref | 1.25 (1.01–1.54) |
| Model 3 aOR (95% CI) | 0.91 (0.66–1.25) | Ref | 1.25 (1.02–1.54) |
| Group 5; BMI ≥ 25.0 (n = 7961) | n = 893 | n = 2488 | n = 4580 |
| Model 1 aOR (95% CI) | 0.87 (0.64–1.20) | Ref | 1.05 (0.86–1.27) |
| Model 2 aOR (95% CI) | 0.86 (0.63–1.18) | Ref | 1.06 (0.88–1.29) |
| Model 3 aOR (95% CI) | 0.87 (0.63–1.19) | Ref | 1.07 (0.88–1.29) |
| Group 1; BMI < 18.5 (n = 10,935) | n = 5550 | n = 3316 | n = 2069 |
| Model 1 aOR (95% CI) | 1.23 (0.79–1.91) | Ref | 1.41 (0.83–2.39) |
| Model 2 aOR (95% CI) | 1.07 (0.68–1.67) | Ref | 1.48 (0.87–2.50) |
| Model 3 aOR (95% CI) | 1.07 (0.68–1.67) | Ref | 1.47 (0.87–2.49) |
| Group 2; BMI 18.5–< 20.0 (n = 17,418) | n = 6310 | n = 6229 | n = 4879 |
| Model 1 aOR (95% CI) | 1.00 (0.71–1.43) | Ref | 1.20 (0.84–1.72) |
| Model 2 aOR (95% CI) | 0.95 (0.66–1.35) | Ref | 1.24 (0.87–1.78) |
| Model 3 aOR (95% CI) | 0.95 (0.66–1.35) | Ref | 1.24 (0.86–1.78) |
| Group 3; BMI 20.0–< 23.0 (n = 27,835) | n = 7248 | n = 9849 | n = 10,738 |
| Model 1 aOR (95% CI) | 0.94 (0.71–1.25) | Ref | 1.03 (0.81–1.32) |
| Model 2 aOR (95% CI) | 0.89 (0.67–1.19) | Ref | 1.06 (0.82–1.35) |
| Model 3 aOR (95% CI) | 0.89 (0.67–1.19) | Ref | 1.05 (0.82–1.35) |
| Group 4; BMI 23.0–< 25.0 (n = 7650) | n = 1054 | n = 2622 | n = 3974 |
| Model 1 aOR (95% CI) | 1.56 (0.79–3.05) | Ref | 1.66 (1.01–2.74) |
| Model 2 aOR (95% CI) | 1.50 (0.76–2.96) | Ref | 1.72 (1.04–2.84) |
| Model 3 aOR (95% CI) | 1.50 (0.76–2.96) | Ref | 1.71 (1.04–2.83) |
| Group 5; BMI ≥ 25 (n = 7961) | n = 893 | n = 2488 | n = 4,580 |
| Model 1 aOR (95% CI) | 0.57 (0.25–1.30) | Ref | 1.00 (0.66–1.53) |
| Model 2 aOR (95% CI) | 0.54 (0.24–1.24) | Ref | 1.07 (0.70–1.63) |
| Model 3 aOR (95% CI) | 0.54 (0.24–1.24) | Ref | 1.07 (0.70–1.63) |
Logistic regression models were used to calculate the adjusted odds ratios and 95% confidence intervals for UmA-pH < 7.20 and for UmA-pH < 7.10, with women with appropriate gestational weight gain as the reference. BMI body mass index, UmA-pH umbilical artery pH.
aModel 1 adjusted for maternal age, maternal education, annual household income, maternal smoking during pregnancy, and parity. Model 2 adjusted for covariates in Model 1 and preterm birth and small-for-gestational age infants. Model 3 adjusted for covariates in Model 2 and mode of delivery.
Adjusted odds ratiosa and 95% confidence intervals for foetal acidosis based on gestational weight gain with vaginal deliveries according to Japanese criteria[28].
| BMI category (kg/m2) | Gestational weight gain | ||
|---|---|---|---|
| Insufficient | Appropriate | Excessive | |
| Group 1; BMI < 18.5 (n = 9321) | n = 4664 | n = 2871 | n = 1786 |
| aOR (95% CI) | 0.85 (0.70–1.04) | Ref | 1.03 (0.81–1.30) |
| Group 2; BMI 18.5–< 20.0 (n = 14,752) | n = 5261 | n = 5294 | n = 4197 |
| aOR (95% CI) | 0.97 (0.83–1.15) | Ref | 1.12 (0.94–1.32) |
| Group 3; BMI 20.0–< 23.0 (n = 22,703) | n = 5807 | n = 8099 | n = 8797 |
| aOR (95% CI) | 0.95 (0.82–1.08) | Ref | 1.00 (0.88–1.12) |
| Group 4; BMI 23.0–< 25.0 (n = 5942) | n = 802 | n = 2015 | n = 3125 |
| aOR (95% CI) | 0.84 (0.58–1.22) | Ref | 1.31 (1.04–1.62) |
| Group 5; BMI ≥ 25 (n = 5627) | n = 597 | n = 1767 | n = 3263 |
| aOR (95% CI) | 0.82 (0.57–1.19) | Ref | 0.97 (0.78–1.21) |
| Group 1; BMI < 18.5 (n = 9321) | n = 4664 | n = 2871 | n = 1786 |
| aOR (95% CI) | 1.30 (0.78–2.16) | Ref | 1.49 (0.81–2.74) |
| Group 2; BMI 18.5–< 20.0 (n = 14,752) | n = 5261 | n = 5294 | n = 4197 |
| aOR (95% CI) | 1.04 (0.69–1.57) | Ref | 1.46 (0.97–2.18) |
| Group 3; BMI 20.0–< 23.0 (n = 22,703) | n = 5807 | n = 8099 | n = 8797 |
| aOR (95% CI) | 0.83 (0.60–1.14) | Ref | 0.96 (0.73–1.26) |
| Group 4; BMI 23.0–< 25.0 (n = 5942) | n = 802 | n = 2015 | n = 3125 |
| aOR (95% CI) | 1.42 (0.59–3.42) | Ref | 2.08 (1.13–3.83) |
| Group 5; BMI ≥ 25 (n = 5627) | n = 597 | n = 1767 | n = 3263 |
| aOR (95% CI) | 0.29 (0.09–0.97) | Ref | 0.80 (0.49–1.31) |
Logistic regression models were used to calculate the adjusted odds ratios and 95% confidence intervals for UmA-pH < 7.20 and for UmA-pH < 7.10, with women with appropriate gestational weight gain as the reference. BMI body mass index, UmA-pH umbilical artery pH.
aAdjusted for maternal age, maternal education, annual household income, maternal smoking during pregnancy, parity, preterm birth and small-for-gestational age infants.
Adjusted odds ratiosa and 95% confidence intervals for foetal acidosis based on gestational weight gain with caesarean section according to Japanese criteria[28].
| BMI category (kg/m2) | Gestational weight gain | ||
|---|---|---|---|
| Insufficient | Appropriate | Excessive | |
| Group 1; BMI < 18.5 (n = 1614) | n = 886 | n = 445 | n = 283 |
| aOR (95% CI) | 0.66 (0.40–1.10) | Ref | 0.82 (0.43–1.56) |
| Group 2; BMI 18.5–< 20.0 (n = 2666) | n = 1049 | n = 935 | n = 682 |
| aOR (95% CI) | 1.00 (0.65–1.55) | Ref | 1.05 (0.65–1.71) |
| Group 3; BMI 20.0–< 23.0 (n = 5132) | n = 1441 | n = 1750 | n = 1941 |
| aOR (95% CI) | 0.93 (0.67–1.29) | Ref | 1.14 (0.85–1.52) |
| Group 4; BMI 23.0–< 25.0 (n = 1708) | n = 252 | n = 607 | n = 849 |
| aOR (95% CI) | 1.20 (0.64–2.23) | Ref | 1.07 (0.67–1.71) |
| Group 5; BMI ≥ 25 (n = 2334) | n = 296 | n = 721 | n = 1317 |
| aOR (95% CI) | 1.04 (0.56–1.94) | Ref | 1.19 (0.79–1.80) |
| Group 1; BMI < 18.5 (n = 1614) | n = 886 | n = 445 | n = 283 |
| aOR (95% CI) | 0.51 (0.19–1.33) | Ref | 1.43 (0.50–4.07) |
| Group 2; BMI 18.5–< 20.0 (n = 2666) | n = 1049 | n = 935 | n = 682 |
| aOR (95% CI) | 0.71 (0.35–1.45) | Ref | 0.65 (0.28–1.49) |
| Group 3; BMI 20.0–< 23.0 (n = 5132) | n = 1441 | n = 1750 | n = 1941 |
| aOR (95% CI) | 1.29 (0.66 –2.51) | Ref | 1.56 (0.86–2.84) |
| Group 4; BMI 23.0–< 25.0 (n = 1708) | n = 252 | n = 607 | n = 849 |
| aOR (95% CI) | 1.68 (0.56–5.01) | Ref | 1.09 (0.44–2.72) |
| Group 5; BMI ≥ 25 (n = 2334) | n = 296 | n = 721 | n = 1317 |
| aOR (95% CI) | 1.63 (0.46–5.69) | Ref | 1.84 (0.75–4.50) |
Logistic regression models were used to calculate the adjusted odds ratios and 95% confidence intervals for UmA-pH < 7.20 and for UmA-pH < 7.10, with women with appropriate gestational weight gain as the reference. BMI body mass index, UmA-pH umbilical artery pH.
aAdjusted for maternal age, maternal education, annual household income, maternal smoking during pregnancy, parity, preterm birth and small-for-gestational age infants.